Reforming patent law in South Africa: Social justice, human rights and big pharma

dc.contributor.advisorKondo, Tinashe
dc.contributor.authorPetersen, Aqeelah
dc.date.accessioned2023-05-04T09:56:54Z
dc.date.accessioned2024-06-05T07:51:27Z
dc.date.available2023-05-04T09:56:54Z
dc.date.available2024-06-05T07:51:27Z
dc.date.issued2022
dc.descriptionMagister Legum - LLMen_US
dc.description.abstractIntellectual property (IP) can be defined as an idea or material that is legally protected from the unauthorised use thereof by other persons, and a person who has invented a particular pharmaceutical drug or medical product will apply for a patent to protect such an invention against counterfeiting and other infringements, which means that only such an inventor can benefit from the manufacturing of a product for a certain period of time, in exchange for public disclosure of the invention. 1 IP first emerged in South Africa as a result of the colonisation of the country by the English.2 As a result, South Africa’s IP system developed to match up to that of England.3 One of the main aims of the colonisers was to benefit themselves at the expense of the colonised.4 Resultantly, they introduced the concept of exclusive rights and monopolies.en_US
dc.identifier.urihttps://hdl.handle.net/10566/15961
dc.language.isoenen_US
dc.publisherUniversity of the Western Capeen_US
dc.rights.holderUniversity of the Western Capeen_US
dc.subjectPharmaceuticalsen_US
dc.subjectWorld Health Organization (WHO)en_US
dc.subjectHuman rightsen_US
dc.subjectLegislationen_US
dc.subjectSouth Africaen_US
dc.titleReforming patent law in South Africa: Social justice, human rights and big pharmaen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
petersen_m_law_2022.pdf
Size:
1.31 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: